NPY Y2 and Y4 receptors selective ligands: promising anti-obesity drugs?

Related Experiment Video

Updated: Jul 10, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

M M Kamiji1, A Inui

  • 1Department of Gastroenterology, Faculty of Medicine, University of Sao Paulo, Ribeirão Preto Campus, Ribeirão Preto, Brazil.

Current Topics in Medicinal Chemistry
|November 6, 2007
PubMed

Insights

Neuropeptide Y (NPY) receptor antagonists, specifically targeting Y(2) and Y(4), show promise for treating obesity. These antagonists may offer a new therapeutic avenue for managing diet-induced obesity and appetite control.

Area of Science:

  • Neuroendocrinology
  • Pharmacology
  • Obesity Research

Background:

  • Neuropeptide Y (NPY) is a key orexigenic peptide in hypothalamic arcuate neurons, regulating ingestive behavior.
  • Mammalian NPY signaling involves at least five receptors: Y(1), Y(2), Y(4), Y(5), and Y(6).
  • Obesity is a global health crisis with increasing prevalence and limited effective pharmacological treatments.

Purpose of the Study:

  • To review the therapeutic potential of targeting Neuropeptide Y receptors for obesity treatment.
  • To highlight the specific roles of Y(2) and Y(4) receptors in combating diet-induced obesity.

Main Methods:

  • Literature review of existing research on Neuropeptide Y receptors and their role in appetite regulation.
  • Analysis of evidence supporting the use of Y(2) and Y(4) receptor antagonists in preclinical models of obesity.

Main Results:

  • Recent findings suggest Y(2) and Y(4) receptors play a protective role against diet-induced obesity.
  • Ligands targeting these receptors demonstrate potential for anti-obesity interventions.

Conclusions:

  • Y(2) and Y(4) receptor antagonists represent a promising therapeutic strategy for human obesity.
  • Targeting these specific NPY receptors could offer a novel approach to appetite suppression and weight management.

More Related Videos

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood11:36

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood

Published on: April 28, 2016

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.